Systemic lupus erythematosus induced by ovulation induction treatment

Area of Science:

• Reproductive endocrinology and immunology.
• Investigating the link between hormonal therapies and autoimmune diseases.

Background:

• Infertile women undergo ovulation induction, leading to elevated serum gonadotropins and estradiol.
• Estradiol, a potent estrogen, influences immune and inflammatory responses.
• Previous studies suggest estrogens may contribute to systemic lupus erythematosus (SLE) development or exacerbation.

Observation:

• Three otherwise healthy women developed systemic lupus erythematosus (SLE) after receiving ovulation induction agents.
• These cases highlight a potential adverse effect of fertility treatments.

Findings:

• The observed cases suggest a possible association between ovulation induction therapy and the onset of SLE.
• Elevated estrogen levels from these treatments might trigger or worsen autoimmune conditions.

Implications:

• Further research is warranted to explore the causal relationship between ovulation induction and SLE.
• This finding may inform clinical practice regarding fertility treatments and autoimmune disease risk assessment.
• Understanding estrogen's role in SLE could lead to new therapeutic strategies.